Keigo Nishida
Papers
2
Total Citations
6
H-Index
2
About
Keigo Nishida is a pioneering urologic surgeon whose research focuses on advancing robotic-assisted surgery and refining treatment strategies for prostate cancer. His work critically examines the therapeutic value of extended pelvic lymph node dissection (ePLND) in intermediate- to high-risk prostate cancer patients undergoing robotic-assisted radical prostatectomy. In a highly cited 2025 study (4 citations), Nishida demonstrated that ePLND may not provide a significant biochemical recurrence benefit, challenging conventional surgical dogma and encouraging more selective, evidence-based lymph node management. Beyond clinical outcomes, Nishida is at the forefront of surgical innovation, evaluating the novel Japanese robotic platform HINOTORI™ against the established da Vinci® system. His comparative study in sacrocolpopexy (2 citations) highlights HINOTORI™’s potential to expand access and improve ergonomics in urologic robot-assisted surgery, including radical prostatectomy and partial nephrectomy. By combining rigorous outcomes research with technology assessment, Nishida is shaping the future of minimally invasive urology—prioritizing patient-centered care while driving adoption of next-generation surgical tools. His work offers critical insights for surgeons and trainees navigating the evolving landscape of robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2